Nintedanib

Nintedanib

Nintedanib is a small molecule tyrosine kinase inhibitor that binds to growth factor receptors, inhibiting the proliferation of fibroblasts. This action reduces ongoing fibrotic processes and delays the progression to long-lasting damage. Nintedanib is indicated for treating idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and progressive phenotype interstitial lung disease. This activity reviews the indications, contraindications, and adverse events associated with nintedanib therapy. The activity also covers the administration, pharmacokinetics, and relevant interactions of nintedanib, providing knowledge crucial for tailoring treatment to individual patient needs.The discussion underscores the importance of the interprofessional healthcare team, focusing on strategies to minimize adverse reactions while maximizing the effectiveness of the treatment. This educational initiative equips healthcare professionals with the necessary tools to safely and effectively administer nintedanib, promoting individualized care for patients undergoing this therapy.

  • Provider:StatPearls, LLC
  • Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/143222
  • Start Date: 2023-09-01 05:00:00
  • End Date: 2023-09-01 05:00:00
  • Credit Details: IPCE Credits: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
    ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
    ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
    ABTS - 1.0 Point; Credit Type(s): Accredited CME (ABTS)
    ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
    ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
    ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
    ABTS - 1.0 Point; Credit Type(s): Self-Assessment (ABTS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Ambulatory/Outpatient, Cardiothoracic, Chemical Pathology, Critical Care, Critical Care Medicine, General Operative Anesthesia, General Surgery, Hospital Medicine, Internal Medicine, Medical Toxicology, Pediatric Critical Care Medicine, Pediatric Pulmonology, Pediatric Rheumatology, Pulmonary Disease, Rheumatology
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.